Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study.
about
Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Glucose-lowering effects and s ...... , multicenter, phase II study.
@en
Glucose-lowering effects and s ...... , multicenter, phase II study.
@nl
type
label
Glucose-lowering effects and s ...... , multicenter, phase II study.
@en
Glucose-lowering effects and s ...... , multicenter, phase II study.
@nl
prefLabel
Glucose-lowering effects and s ...... , multicenter, phase II study.
@en
Glucose-lowering effects and s ...... , multicenter, phase II study.
@nl
P2093
P2860
P921
P1476
Glucose-lowering effects and s ...... , multicenter, phase II study.
@en
P2093
Hubert S Chou
Kazuhito Shiosakai
Nobuya Inagaki
Shuji Tsukiyama
Takuo Washio
Yasuhiko Nakatsuka
P2860
P304
P356
10.1136/BMJDRC-2017-000424
P577
2017-09-29T00:00:00Z